[Pharma-Clinics. The drug of the month. Adapalene (Differin gel)]
- PMID: 9564232
[Pharma-Clinics. The drug of the month. Adapalene (Differin gel)]
Abstract
Adapalene is a new topical retinoid derived from naphthoic acid with a selective effect on the epidermis. It is indicated for treatment of acne vulgaris, alone or with other antiacneic topicals. It displays comedolytic and anti-inflammatory activities. The only frequent adverse event is a mild skin irritation during the first two weeks of treatment.
Similar articles
-
Spotlight on adapalene in acne vulgaris.Am J Clin Dermatol. 2004;5(5):369-71. doi: 10.2165/00128071-200405050-00014. Am J Clin Dermatol. 2004. PMID: 15554742 Review.
-
Adapalene: a review of its use in the treatment of acne vulgaris.Drugs. 2004;64(13):1465-78. doi: 10.2165/00003495-200464130-00005. Drugs. 2004. PMID: 15212561 Review.
-
Is switching retinoids a sound strategy for the treatment of acne vulgaris?J Drugs Dermatol. 2008 Jun;7(6 Suppl):s11-7. J Drugs Dermatol. 2008. PMID: 18575221 Clinical Trial.
-
Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.Br J Dermatol. 2004 Aug;151(2):481-4. doi: 10.1111/j.1365-2133.2004.06067.x. Br J Dermatol. 2004. PMID: 15327558 Clinical Trial.
-
Trifarotene (Aklief) - a new topical retinoid for acne.Med Lett Drugs Ther. 2019 Dec 16;61(1587):195-197. Med Lett Drugs Ther. 2019. PMID: 31999666 No abstract available.